Their products, such as Venus 2000 and VO 100, allow clinicians to assess cardiac conditions without invasive measurements. They also offer the VenArt system, which provides continuous assessment of arterial and venous oximetry. Mespere's newest product, NeurOs, is a cerebral tissue oximetry system that accurately monitors tissue vascular filling. Their solutions are cost-effective, easy to use, and validated against invasive methods, making them reliable for various clinical applications. Mespere aims to improve patient outcomes by providing hospitals with better hemodynamic monitoring options.